Immunicon Corporation Announces FDA Clearance of the CellSearch(TM) Circulating Tumor Cell Kit for Monitoring Patients with Metastatic Prostate Cancer Wednesday February 27, 6:06 pm ET Diagnostic Test Is Now Cleared for Three of the Four Most Common Cancers http://biz.yahoo.com/bw/080227/20080227006321.html?.v=1
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.